Endurance Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$2.34M Buy
30,434
+375
+1% +$29K 0.32% 65
2023
Q1
$2.26M Sell
30,059
-35
-0.1% -$2.6K 0.32% 62
2022
Q4
$2.37M Sell
30,094
-50
-0.2% -$3.75K 0.36% 57
2022
Q3
$2.12M Sell
30,144
-154
-0.5% -$12.1K 0.35% 62
2022
Q2
$2.43M Buy
30,298
+355
+1% +$27.8K 0.37% 60
2022
Q1
$2.27M Sell
29,943
-684
-2% -$54.2K 0.29% 68
2021
Q4
$2.61M Sell
30,627
-5
-0% -$390 0.28% 75
2021
Q3
$2.31M Sell
30,632
-345
-1% -$27.4K 0.26% 86
2021
Q2
$2.52M Sell
30,977
-976
-3% -$79.8K 0.28% 81
2021
Q1
$2.52M Buy
31,953
+85
+0.3% +$6.66K 0.3% 79
2020
Q4
$2.73M Buy
31,868
+50
+0.2% +$4.13K 0.34% 73
2020
Q3
$2.46M Sell
31,818
-1,027
-3% -$78.3K 0.36% 67
2020
Q2
$2.41M Sell
32,845
-100
-0.3% -$7.1K 0.39% 65
2020
Q1
$2.19M Buy
32,945
+1,256
+4% +$88.6K 0.42% 62
2019
Q4
$2.18M Buy
31,689
+100
+0.3% +$6.82K 0.33% 71
2019
Q3
$2.32M Sell
31,589
-3,785
-11% -$275K 0.39% 64
2019
Q2
$2.54M Sell
35,374
-326
-0.9% -$23.1K 0.4% 61
2019
Q1
$2.45M Hold
35,700
0.4% 64
2018
Q4
$2.13M Buy
35,700
+25
+0.1% +$1.56K 0.4% 63
2018
Q3
$2.39M Sell
35,675
-1,374
-4% -$91.5K 0.38% 67
2018
Q2
$2.4M Sell
37,049
-200
-0.5% -$13.1K 0.4% 64
2018
Q1
$2.67M Buy
37,249
+272
+0.7% +$19.6K 0.45% 59
2017
Q4
$2.79M Sell
36,977
-530
-1% -$38.7K 0.45% 61
2017
Q3
$2.73M Sell
37,507
-1,599
-4% -$115K 0.45% 58
2017
Q2
$2.9M Sell
39,106
-51
-0.1% -$3.79K 0.49% 55
2017
Q1
$2.87M Sell
39,157
-764
-2% -$53.5K 0.5% 55
2016
Q4
$2.61M Sell
39,921
-3,948
-9% -$271K 0.47% 57
2016
Q3
$3.19M Sell
43,869
-1,824
-4% -$135K 0.57% 52
2016
Q2
$3.34M Sell
45,693
-508
-1% -$36.2K 0.63% 48
2016
Q1
$3.26K Sell
46,201
-950
-2% -$63.2K 0.46% 48
2015
Q4
$3.14M Buy
47,151
+500
+1% +$33.3K 0.6% 50
2015
Q3
$3.09M Buy
46,651
+1,358
+3% +$88.7K 0.54% 55
2015
Q2
$2.96M Buy
45,293
+903
+2% +$61.3K 0.5% 60
2015
Q1
$3.08M Sell
44,390
-3,755
-8% -$260K 0.54% 55
2014
Q4
$3.33M Sell
48,145
-350
-0.7% -$23.6K 0.6% 52
2014
Q3
$3.16M Buy
48,495
+76
+0.2% +$5.01K 0.59% 50
2014
Q2
$3.3M Buy
48,419
+704
+1% +$47.2K 0.55% 51
2014
Q1
$3.1M Buy
47,715
+534
+1% +$33.7K 0.6% 51
2013
Q4
$3.08M Sell
47,181
-930
-2% -$59.5K 0.61% 50
2013
Q3
$2.85M Sell
48,111
-194
-0.4% -$11.5K 0.6% 48
2013
Q2
$2.77M Buy
+48,305
New +$2.87M 0.62% 50

Other funds holding CL

Endurance Wealth Management's CL Position: Q2 2023 in Review

Endurance Wealth Management increased its Colgate-Palmolive (CL) stake by 1.2% in Q2 2023, buying an estimated $29K and bringing the position to 30,434 shares worth $2.34M. The position accounts for 0.32% of the portfolio, ranked #65.

Endurance Wealth Management first reported a position in CL in Q2 2013 and has held it in 41 quarters since. The position peaked at $3.34M in Q2 2016. 1,680 funds tracked by Wall St. Rank hold CL as of Q2 2023.

  • Endurance Wealth Management held 30,434 shares of Colgate-Palmolive worth $2.34M as of Q2 2023.
  • Endurance Wealth Management bought 375 Colgate-Palmolive shares in Q2 2023, an estimated $29K.
  • Colgate-Palmolive made up 0.32% of Endurance Wealth Management's portfolio in Q2 2023, its #65 holding.
  • Endurance Wealth Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 41 quarters since.
  • Endurance Wealth Management's Colgate-Palmolive position peaked at $3.34M in Q2 2016.
  • 1,680 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.